Cite
MLA Citation
Tetsu Tomonari et al.. “Comparison of therapeutic outcomes of sorafenib and lenvatinib as primary treatments for hepatocellular carcinoma with a focus on molecular‐targeted agent sequential therapy: A propensity score‐matched analysis.” Hepatology research, vol. 51, no. 4, 2021, pp. 472–481. http://access.bl.uk/ark:/81055/vdc_100124375162.0x000041